SCHEMBL4940737

SCHEMBL4940737

O=Cc1cccc(N2CCC(CN3CCCC3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MBTD1 Q05BQ5 1/20 0.44
TP53BP1 Q12888 1/20 0.44
DRD2 P14416 1/20 0.43
DRD1 P21728 1/20 0.43
DRD4 P21917 1/20 0.43
DRD5 P21918 1/20 0.43
DRD3 P35462 1/20 0.43
LMNA P02545 2/20 0.43
THRB P10828 2/20 0.43
MAPT P10636 1/20 0.43
KCNH2 Q12809 4/20 0.41
HRH1 P35367 3/20 0.41
CCR3 P51677 3/20 0.41
HTR7 P34969 1/20 0.41
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
HTR1A P08908 2/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4935664 0.83 TRIM24 (0.62) L3MBTL3L3MBTL1MBTD1TP53BP1TRIM24
SCHEMBL1443579 0.81 TRIM24 (0.60) MAPTHTR7TRIM24TRIM33ALDH1A1
SCHEMBL29377692 0.81 TRIM24 (0.60) MAPTHTR7TRIM24TRIM33ALDH1A1
SCHEMBL30770827 0.79 ALDH1A1 (0.61) L3MBTL1LMNAMAPTHTR7TRIM24
SCHEMBL1418736 0.79 ALDH1A1 (0.61) L3MBTL1LMNAMAPTHTR7TRIM24
SCHEMBL4935659 0.78 L3MBTL1 (0.71) L3MBTL3L3MBTL1MBTD1TP53BP1DRD2
SCHEMBL24233918 0.78 MBTD1 (0.56) L3MBTL3L3MBTL1MBTD1DRD2DRD4
SCHEMBL2323342 0.77 ALDH1A1 (0.45) DRD2DRD1DRD4DRD5DRD3
SCHEMBL4935029 0.77 L3MBTL3 (0.69) L3MBTL3L3MBTL1MBTD1TP53BP1DRD2
SCHEMBL4941255 0.76 ALDH1A1 (0.68) L3MBTL1LMNATHRBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines APODACA RICHARD L 2008-01-03 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
US-7279491-B2 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2007-10-09 US disclosed
EP-1556046-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2005-07-27 EP disclosed
WO-2004037257-A1 PHENYLPIPERIDINES AND PHENYLPYRROLIDINES AS HISTAMINE H3 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-05-06 WO disclosed
US-20040087573-A1 Phenylpiperidines and phenylpyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087573-A1 Phenylpiperidines and phenylpyrrolidines HRH2, HNMT, HRH3 L3MBTL3 4833/4885L3MBTL1 4814/4885MBTD1 3982/4885
US-20080004314-A1 Phenylpiperidines and Phenylpyrrolidines HRH2, HNMT, HRH3 L3MBTL3 4833/4885L3MBTL1 4814/4885MBTD1 3982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.